RCEL(AVITA Medical, Inc.) · 财务报表

RCEL(AVITA Medical, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-06-30FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$29.23M$34.42M$50.14M$64.25M$71.61M
毛利润$23.28M$28.38M$42.36M$55.16M$58.82M
营业利润−$26.54M−$27.50M−$42.66M−$56.59M−$42.53M
净利润−$26.58M−$26.66M−$35.38M−$61.84M−$48.59M
经营现金流−$25.90M−$19.09M−$38.01M−$48.94M−$31.20M
自由现金流−$26.80M−$19.54M−$39.39M−$58.11M−$32.20M
摊薄每股收益——$-1.40$-2.39$-1.74

AVITA Medical, Inc. RCEL